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Abstract 
Background: Glutathione S-transferase (GST) enzyme levels are associated with the 
risk of many cancers, including hematological malignancies. Conflicts in the published 
results and the absence of similar in-depth studies in Sudan prompted us to perform the 
present investigation to detect a possible association between polymorphisms at the 
GSTT gene and susceptibility to develop ALL in a Sudanese population.  
Objectives:  This study aimed to investigate the relationships between GSTT1 
polymorphisms and the risk of acute lymphoblastic leukemia (ALL). 
Materials and Methods: A total of 40 patients with ALL and 30 control subjects were 
enrolled in this case control study. Blood samples were collected from all patients and 
controls in EDTA. Genomic DNA was extracted from all blood samples using salting 
out method. Genotyping for detection of GSTT1 polymorphism was performed for both 
patients and controls using an allele-specific PCR  
Results: GSTT1 null genotype was detected in 53% of ALL patients (21/40) and in 
17% (5/30) of the control group, and GSTT1 present genotype was detected in 47% 
(19/40) in ALL patients group and in 83% (25/30) of the control group. We reported 
that there is an association between the GSTT1 null genotype and ALL risk (OR= 5.5, 
95% CI= 1.7616 to 17.3364; P = 0.003).  
Conclusion: This study reported that there was an association between the GSTT1 null 
genotype and ALL risk(OR=5.5, 95% CI=1.7616 to 17.3364; P=0.003) appear also to 
have an influence in the development of ALL. 
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Introduction  
Glutathione S-transferases (GSTs) are a supergene family of detoxifying enzymes 
which are found in virtually all life forms (1). GSTs are phase II detoxifying enzymes 
that catalyze the conjugation of reduced glutathione with a wide variety of electrophilic 
substrates (2). In addition to their function in xenobiotic detoxification, GSTs have 
peroxidase and isomerase activities that can inhibit the c-Jun N-terminal kinase (JNK) 
(3). GSTs can also bind non-catalytically with a wide range of endogenous and 
exogenous ligands (3). In humans, GST enzymes consist of many cytosolic, 
mitochondrial, and microsomal proteins, and the cytosolic family has eight distinct 
classes: alpha (A), kappa (K), mu (M), omega (O), pi (P), sigma (S), theta (T), and zeta 
(Z) (4, 1). Among the numerous GST genes, GSTM1 and GSTT1 genes have been 
extensively studied because of the high prevalence of homozygous deletions of these 
genes, which have been associated with the loss of enzyme activity with a decreased 
ability to detoxify and increase vulnerability to cytogenetic damage, placing null 
individuals at increase cancer risk (5-7). GSTT1 is represented by two alleles: a 
functional or wild allele (GSTT1*1), and a nonfunctional or null allele (GSTT1*0). 
Studies have shown that the total or partial deletion of the gene (GSTT1*0 allele) 
causing a deficiency in its enzymatic activity (8). Moreover, numerous studies have 
evaluated the association between polymorphisms of GSTs gene and the susceptibility 
to develop various types of cancer, such as gastric cancer, oral cancer, bladder cancer, 
and chronic myeloid leukemia CML in different ethnical groups worldwide (9).To the 
best of our knowledge this is the first study conducted in Sudan to investigate the 
association between the GSTT1 polymorphism in ALL patients. The present study was 
conducted to detect a possible association between polymorphisms at the GSTT gene 
and Risk of ALL. in a Sudanese population. 
 
Materials and Methods 
In this case-control study a total of forty patients newly diagnosed with ALLwere 
recruited from the Radio Isotope Center Khartoum (RICK) Sudan in the period from 
October 2014 to March 2015. Additionally, thirty healthy age and gender-matched 
children served as control group.  
Ethics approval and consent to participate 
The authorized guardians of both patients with ALL and controls had given informed 
written consent after clarifying the nature, steps, and aim of the study. The study was 
conducted with the approval of the Ethics Committee of Sudan University of Science 
and technology. 
 
Blood sample collection.  
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Peripheral blood samples were obtained by venipuncture using a sterile aseptic 
technique. Four ml of peripheral Blood samples were collected in EDTA tube for DNA 
extraction and genotyping. 
DNA extraction 
Genomic DNA was extracted by the salting out method(10).  To assess the DNA quality 
after DNA extraction, the β-globin gene amplification was used to evaluate the quality 
of DNA in all extracted samples, as previously described(11). All specimens for β-globin 
gene showed successful amplification, (Primers shown in Table 1). To evaluate the 
DNA quantification after DNA extraction, we measured DNA by using a NanoDrop 
spectrophotometer.A260:280 ratios greater than 1.8 were considered indicators for 
highly pure DNA. Then DNA samples were routinely stored at -20℃. 
Genotyping of GSTT1 polymorphism 
Genotyping was carried out by using the polymerase chain reaction with allele specific 
primers as described previously (12). The primer sequences for genotyping are shown in 
Table 1. PCR was performed by using Maxime PCR Premix Kit (i-Taq), (iNtRON 
BIOTECHNOLOGY, South Korea), Cat. No. 25025), 4µl of genomic DNA, 0.5 µl of 
each primer, and 14 µl distilled water. The thermal profile was 94°C for 5 minutes as 
initial denaturation, followed by 35 cycles each cycle of 95°C for 60 seconds, 60°C for 
60secnds, and 72°C for 60 seconds, with a final extension at 72°C for 5 min. Thermo 
cycling was carried out on the TECHNE Tc-412-UK PCR Thermal Cycler 96 well 
(TECHNE, UK).Amplified products were electrophoretically separated through 1.5 % 
agarose gels and 0.5X TBE buffer and visualized under UV light with ethidium bromide 
staining using Dolphin Doc gel documentation system  
GSTT1 genotype was specified by bands of 480 bp, the GSTT1 Null genotype showed 
one band of 480 bp, hence the use of β-globin gene as internal positive control was 
important to identify the null genotype from aborted PCR responses. 
 
Table (1):The primers sequence forGSTT1 polymorphismsG Polymorphism 
Product size (bp) Sequence Primer  
480 bp 5'-TTCCTTACTGGTCCTCACATCTC-3', GSTT1 forward  
5'-TCACCGGATCATGGCCAGCA-3' GSTT1 reverse  
268 bp 5'-CAACTTCATCCACGTTCACC-3', ß-globin forward  
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Statistical analysis 
Patient’s data was collected by structured interview questionnaire and from patients 
medical files and analyzed using the statistical package for social sciences (SPSS) 
version 16.0 software (Chicago, IL, USA). Logistic regression was used for calculation 
of odds ratio (OR) with confidence interval (CI) for risk estimation 
Results  
A total of 70 study subjects comprising forty ALL patients (19 males, 11 females, mean 
age 12.2 years) and thirty healthy (29 males, 11 females, mean age 14.2 years) controls 
were studied.  The frequencies of GSTT1 null genotype were higher in ALL patients 
53% (21/40) than in control`s group 17% (5/30). However, for the GSTT1 precent 
genotype frequencies were 47 % (19/41) in patients’ group and 83% (25/30) in controls’ 
group. Statistically, significant difference was observed (OR= 5.5, 95% CI= 1.7616 to 
17.3364; P.value= 0.003) (Table 2). In ALL patients GSTT1 was null in 38% of males 
and 13% of females and presented in 33% of males and 16% of females whereas in 
control group GSTT1 was null in 4% of males and 13% of females and presented in 
63% of males and 20% of females. 
Table 2: Frequency of GSTT1 genotypes in ALL patients and controls 
Group ALL Patients Control Odd Ratio P. 
Value 
95% CI 
GSTT1 Null 47%  17% 5.5 0.003 1.8-17.3 
GSTT1 Present 53% 83% 
 
Discussion  
Glutathione s-transferase (GSTs) polymorphisms (GSTM1, GSTP1 and GSTT1) have 
been reported to be risk factors for developing solid cancers and leukemias in many 
published reports; several studies reported the association between GSTT1 
polymorphisms and risk of childhood acute lymphoblastic leukemia.Genetic variability 
of GST genes was evaluated in leukemic and healthy Sudanese since ethnicity has been 
related to differences in the occurrence of acute leukemia (13), and notable variances in 
the pattern of GST frequencies were described worldwide (14,15).In this case-control 
study, we found that the GSTT1 deletion polymorphisms were associated with risk of 
ALL, this finding is like that found in earlier studies on childhood ALL patients. 
However, the odds ratio obtained in this study is much higher than in the previous 
studies (16). The findings of the percent study are partially agreeing with study done in 
India (17) which demonstrated that GSTT1 null genotypes may be considered 
independent risk factors for ALL. This study indicated GSTT polymorphism was a 
promising candidate biomarker for evaluating the ALL risk. There are several previous 
studies which investigated the association between GSTT1 polymorphisms and risk of 
ALL (16, 18), but the results are different. There is a case-control study conducted in the 
Singapore by Chan et al, and the results support the hypothesis that the GSTT1 gene 
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deletion is related to the risk of ALL (19). Clavelhas reported that the variation in GSTT1 
genotype was not associated with the susceptibility of risk of development of ALL in a 
French population (20). The results obtained in our study indicating that GSTT1 null 
genotype is a risk factor for childhood leukemia agree with earlier publications in Sudan 
(21) indicating that GSTT1 null genotype may increase individual susceptibility to AML. 
The explanations for the variations between different studies are not clear. However, 
some clarifications can be proposed including that the differences may be due to 
variable geographical distribution and some interethnic variances may be involved 
 
Conclusion  
These results imply that genetic variants of GSTT1 gene influence the risk of 
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